E2F8 is found to be significantly overexpressed in HCC, and it promotes the occurrence and development of HCC by activating E2F1/cyclin D1 signaling pathway to regulate the G1-S phase transition of cell cycle [33]. Here, E2F1 is linked to hepatocellular carcinoma.